Search clinical trials for: histone deacetylases
Total 727 results
-
State University of New York - Upstate Medical...CompletedBladder Cancer | HematuriaUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumors | Hematological MalignanciesUnited States
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminatedBrain Cancer | Glioblastoma MultiformeUnited States
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
Novartis PharmaceuticalsTerminatedCutaneous T-Cell LymphomaUnited States
-
University of LeedsMerck Sharp & Dohme LLC; Myeloma UKCompletedMultiple MyelomaUnited Kingdom
-
George Washington UniversityTerminatedProstate AdenocarcinomaUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential ThrombocytopeniaUnited States
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft Versus Host Disease | GVHDUnited States
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, ChronicUnited States, Germany
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia in Chronic PhaseBelgium, Germany
-
Novartis PharmaceuticalsTerminatedMultiple MyelomaUnited States, Germany
-
Taizhou EOC Pharma Co., Ltd.Active, not recruiting
-
Novartis PharmaceuticalsCompletedIdiopathic Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia-Vera MyelofibrosisUnited Kingdom, Ireland, Germany, Italy, France
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States
-
Pamela MunsterPfizer; Xynomic Pharmaceuticals, Inc.WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
ItalfarmacoCompleted
-
University of BirminghamMerck Sharp & Dohme LLC; Celgene; Leukemia Research FundCompletedLeukemia, Myeloid, AcuteUnited Kingdom
-
ItalfarmacoCompletedActive Systemic | Onset Juvenile Idiopathic ArthritisRomania, Serbia
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Mirati Therapeutics Inc.TerminatedAdvanced CancerUnited States
-
ItalfarmacoParexelTerminatedJuvenile Idiopathic ArthritisCzechia
-
Johns Hopkins All Children's HospitalTerminatedCentral Nervous System TumorsUnited States
-
Merck Sharp & Dohme LLCCompleted
-
M.D. Anderson Cancer CenterCompleted
-
National Cancer Institute (NCI)TerminatedStage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaSyndax PharmaceuticalsWithdrawn
-
Columbia UniversityNational Cancer Institute (NCI); Acetylon Pharmaceuticals IncorporatedCompletedMetastatic Breast Cancer | Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNovartisCompletedHodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
Novartis PharmaceuticalsCompletedProstate CancerCanada, United States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
Novartis PharmaceuticalsCompleted
-
Texas A&M UniversityNational Cancer Institute (NCI); Oregon Health and Science UniversityCompletedColon CancerUnited States
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML)Japan
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | MesotheliomaUnited States, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)Germany, Spain, United States
-
Novartis PharmaceuticalsCompletedCancerUnited States, Switzerland, Sweden
-
Novartis PharmaceuticalsCompletedMultiple MyelomaFrance, Australia, United States, Spain